DK1948131T3 - Dexpanthenol-, calciumion- og phosphatfri farmaceutisk sammensætning samt anvendelse af calciumchelatdannere og oftalmologisk kompatible viskositetsregulatorer - Google Patents
Dexpanthenol-, calciumion- og phosphatfri farmaceutisk sammensætning samt anvendelse af calciumchelatdannere og oftalmologisk kompatible viskositetsregulatorerInfo
- Publication number
- DK1948131T3 DK1948131T3 DK06818627T DK06818627T DK1948131T3 DK 1948131 T3 DK1948131 T3 DK 1948131T3 DK 06818627 T DK06818627 T DK 06818627T DK 06818627 T DK06818627 T DK 06818627T DK 1948131 T3 DK1948131 T3 DK 1948131T3
- Authority
- DK
- Denmark
- Prior art keywords
- calcium
- pharmaceutical composition
- dexpanthenol
- well
- chelating agents
- Prior art date
Links
- 239000003715 calcium chelating agent Substances 0.000 title abstract 3
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 3
- BHPQYMZQTOCNFJ-UHFFFAOYSA-N Calcium cation Chemical compound [Ca+2] BHPQYMZQTOCNFJ-UHFFFAOYSA-N 0.000 title abstract 2
- SNPLKNRPJHDVJA-ZETCQYMHSA-N D-panthenol Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCCO SNPLKNRPJHDVJA-ZETCQYMHSA-N 0.000 title abstract 2
- 235000004866 D-panthenol Nutrition 0.000 title abstract 2
- 239000011703 D-panthenol Substances 0.000 title abstract 2
- 229910001424 calcium ion Inorganic materials 0.000 title abstract 2
- 229910000389 calcium phosphate Inorganic materials 0.000 title abstract 2
- 229960003949 dexpanthenol Drugs 0.000 title abstract 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 title abstract 2
- 239000010452 phosphate Substances 0.000 title abstract 2
- 230000007547 defect Effects 0.000 abstract 1
- 239000000546 pharmaceutical excipient Substances 0.000 abstract 1
- 229940124531 pharmaceutical excipient Drugs 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
- A61K31/728—Hyaluronic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
- C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
- C08B37/0072—Hyaluronic acid, i.e. HA or hyaluronan; Derivatives thereof, e.g. crosslinked hyaluronic acid (hylan) or hyaluronates
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Ophthalmology & Optometry (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Inorganic Chemistry (AREA)
- Materials Engineering (AREA)
- Biochemistry (AREA)
- Polymers & Plastics (AREA)
- Dermatology (AREA)
- Pulmonology (AREA)
- Transplantation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Detergent Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE102005055275A DE102005055275A1 (de) | 2005-11-17 | 2005-11-17 | Phosphatfreie pharmazeutische Zusammensetzung sowie deren Verwendung |
| PCT/EP2006/011053 WO2007057201A2 (fr) | 2005-11-17 | 2006-11-17 | Composition pharmaceutique exempte de dexpanthenol, d'ions calcium et de phosphate, utilisation de chelateurs du calcium et d'un regulateur de viscosite acceptable sur le plan ophtalmique |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1948131T3 true DK1948131T3 (da) | 2009-07-13 |
Family
ID=37989463
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK06818627T DK1948131T3 (da) | 2005-11-17 | 2006-11-17 | Dexpanthenol-, calciumion- og phosphatfri farmaceutisk sammensætning samt anvendelse af calciumchelatdannere og oftalmologisk kompatible viskositetsregulatorer |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US8648057B2 (fr) |
| EP (1) | EP1948131B3 (fr) |
| JP (1) | JP2009515921A (fr) |
| CN (1) | CN101312711B (fr) |
| AT (1) | ATE425742T1 (fr) |
| CA (1) | CA2630193C (fr) |
| CY (1) | CY1109112T1 (fr) |
| DE (2) | DE102005055275A1 (fr) |
| DK (1) | DK1948131T3 (fr) |
| ES (1) | ES2324118T7 (fr) |
| PL (1) | PL1948131T6 (fr) |
| PT (1) | PT1948131E (fr) |
| SI (1) | SI1948131T1 (fr) |
| WO (1) | WO2007057201A2 (fr) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ITPD20070208A1 (it) * | 2007-06-19 | 2008-12-20 | Alessandro Filippo | Metodo di umidificazione di una lente a contatto |
| MX349176B (es) | 2008-09-22 | 2017-07-14 | Biochemics Inc | Suministro transdermico de farmaco empleando un osmolito y un agente vasoactivo. |
| DE102009021372A1 (de) | 2009-05-14 | 2010-11-18 | Ursapharm Arzneimittel Gmbh | Phosphatfreie pharmazeutische Zusammensetzung zur Glaukombehandlung |
| AT511164A1 (de) | 2011-03-03 | 2012-09-15 | Croma Pharma Gmbh | Verwendung eines viskoelastischen fluids zur herstellung eines medizinproduktes für die chirurgische behandlung des auges |
| EP3613423B1 (fr) | 2013-07-10 | 2022-10-26 | Matrix Biology Institute | Compositions d'hyaluronane à forte élasticité et leurs utilisations |
| FR3019465B1 (fr) | 2014-04-02 | 2017-06-23 | Horus Pharma | Composition hyperosmolaire d'acide hyaluronique et son utilisation pour le traitement de l'oedeme corneen |
| CN108135926A (zh) * | 2015-09-24 | 2018-06-08 | 基质生物研究所 | 高弹性透明质酸组合物及其使用方法 |
| ITUB20160543A1 (it) * | 2016-02-08 | 2017-08-08 | Sooft Italia S P A 63833 Montegiorgio Fermo / Italia | Composizione oftalmica stabilizzante e reintegrante del film lacrimale per uso nella prevenzione delle infezioni virali |
| AU2018230262B2 (en) | 2017-03-05 | 2024-01-18 | Resdevco Research And Development Co. Ltd. | Eye drops for treatment of irritation not due to infection |
| WO2019060696A1 (fr) | 2017-09-25 | 2019-03-28 | Surface Pharmaceuticals, Inc. | Compositions pharmaceutiques opthalmiques et procédés pour le traitement de maladie de surface oculaire |
| WO2019202017A1 (fr) * | 2018-04-18 | 2019-10-24 | i.com medical GmbH | Acide hyaluronique de poids moléculaire élevé pour le traitement et la prévention d'une maladie de surface oculaire grave |
| BR112021000863A2 (pt) * | 2018-05-01 | 2021-04-13 | Jinan Cao | Colírios que curam cataratas, presbiopia e |
| JP2020075918A (ja) * | 2018-11-02 | 2020-05-21 | 千寿製薬株式会社 | 角膜上皮創傷治癒促進用の眼科用組成物 |
| RU2679319C1 (ru) * | 2018-11-27 | 2019-02-07 | Илья Александрович Марков | Гелеобразная искусственная слеза с антисептическим и репаративным действием |
| KR20210141448A (ko) | 2018-12-27 | 2021-11-23 | 서피스 아프샐믹스 인코포레이티드 | 안구 표면 질환을 치료하기 위한 안과용 약학 조성물 및 방법 |
| US12268706B2 (en) | 2019-01-31 | 2025-04-08 | i.com medical GmbH | Hyaluronic acid for relief of idiopathic ocular pain |
| US12310981B2 (en) | 2021-05-10 | 2025-05-27 | Surface Ophthalmics, Inc. | Use of chondroitin sulfate for relieving ocular pain |
| US12440510B2 (en) | 2021-05-10 | 2025-10-14 | Surface Ophthalmics, Inc. | Use of chondroitin sulfate for relieving ocular pain |
Family Cites Families (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4409205A (en) * | 1979-03-05 | 1983-10-11 | Cooper Laboratories, Inc. | Ophthalmic solution |
| WO1984004681A1 (fr) * | 1983-05-25 | 1984-12-06 | Alcon Lab Inc | Solution ophtalmique |
| US4629623A (en) * | 1984-06-11 | 1986-12-16 | Biomatrix, Inc. | Hyaluronate-poly (ethylene oxide) compositions and cosmetic formulations thereof |
| US5705485A (en) * | 1987-09-18 | 1998-01-06 | Ethicon, Inc. | Gel formulations containing growth factors |
| JPH075456B2 (ja) * | 1988-10-01 | 1995-01-25 | 参天製薬株式会社 | 点眼液 |
| EP0414373B2 (fr) * | 1989-07-24 | 2001-04-25 | Allergan Pharmaceuticals (Ireland) Limited | Solution stable d'hyaluronate dans un milieu salin équilibré |
| US6271216B1 (en) * | 1989-07-24 | 2001-08-07 | Allergan | Stable solution of hyaluronate in a balanced salt medium |
| JPH07116030B2 (ja) * | 1990-06-29 | 1995-12-13 | 参天製薬株式会社 | 残留水晶体物質除去補助剤 |
| JPH0748262A (ja) | 1993-06-04 | 1995-02-21 | Senju Pharmaceut Co Ltd | 外眼部投与用組成物 |
| IT1273011B (it) | 1994-07-25 | 1997-07-01 | Trhecnopharma S A | Preparato oftalmico per l'uso come lacrima artificiale |
| DE19729879C2 (de) * | 1997-07-11 | 1999-07-08 | Mann Gerhard Chem Pharm Fab | Lagerstabile ophthalmische Zusammensetzungen, umfassend Diclofenac und Ofloxacin |
| AU2001285006A1 (en) * | 2000-08-21 | 2002-03-04 | Bausch And Lomb Surgical, Inc. | Prevention of posterior capsular opacification by endocapsular circulation of chemical agents |
| IL156766A0 (en) * | 2001-01-09 | 2004-02-08 | Louis Johan Wagenaar | Procedure and composition of treatment and/or care of the eye |
| JP2003002837A (ja) * | 2001-06-21 | 2003-01-08 | Lion Corp | 水性外用剤組成物及び液体組成物の白濁防止方法 |
| DE10161149B4 (de) * | 2001-12-12 | 2007-03-08 | Ursapharm Arzneimittel Gmbh & Co. Kg | Verwendung von Heparin-haltigem Ophthalmikum |
| DE10161110A1 (de) * | 2001-12-12 | 2003-06-26 | Ursapharm Arzneimittel Gmbh | Pharmazeutische Zusammensetzung zur ophthalmologischen und rhinologischen Anwendung |
| JP2003206241A (ja) * | 2002-01-11 | 2003-07-22 | Teika Seiyaku Kk | 眼科用剤 |
| JP4263456B2 (ja) * | 2002-03-18 | 2009-05-13 | わかもと製薬株式会社 | ヒアルロン酸含有熱ゲル化製剤 |
| JP2004059432A (ja) | 2002-06-04 | 2004-02-26 | Rohto Pharmaceut Co Ltd | 角膜障害治療剤 |
| JP4603976B2 (ja) * | 2002-10-31 | 2010-12-22 | 千寿製薬株式会社 | 角膜障害治療剤 |
| GB0225518D0 (en) | 2002-11-01 | 2002-12-11 | Airbus Uk Ltd | Welding method |
| US7083803B2 (en) * | 2003-09-19 | 2006-08-01 | Advanced Ocular Systems Limited | Ocular solutions |
| EP1681065A4 (fr) * | 2003-10-31 | 2011-12-28 | Wakamoto Pharma Co Ltd | Composition a base d'eau soumise a une thermoregulation reversible |
| JP2005239622A (ja) | 2004-02-26 | 2005-09-08 | Rohto Pharmaceut Co Ltd | 角膜障害治療剤 |
| CN1997381B (zh) | 2004-04-23 | 2011-06-08 | 千寿制药株式会社 | 含有pacap及其衍生物的角膜神经突形成促进剂 |
| US8569367B2 (en) * | 2004-11-16 | 2013-10-29 | Allergan, Inc. | Ophthalmic compositions and methods for treating eyes |
-
2005
- 2005-11-17 DE DE102005055275A patent/DE102005055275A1/de not_active Ceased
-
2006
- 2006-11-17 SI SI200630310T patent/SI1948131T1/sl unknown
- 2006-11-17 PT PT06818627T patent/PT1948131E/pt unknown
- 2006-11-17 JP JP2008540522A patent/JP2009515921A/ja active Pending
- 2006-11-17 WO PCT/EP2006/011053 patent/WO2007057201A2/fr not_active Ceased
- 2006-11-17 DE DE502006003215T patent/DE502006003215D1/de active Active
- 2006-11-17 ES ES06818627T patent/ES2324118T7/es active Active
- 2006-11-17 PL PL06818627T patent/PL1948131T6/pl unknown
- 2006-11-17 EP EP06818627A patent/EP1948131B3/fr active Active
- 2006-11-17 US US12/084,803 patent/US8648057B2/en active Active
- 2006-11-17 DK DK06818627T patent/DK1948131T3/da active
- 2006-11-17 CA CA2630193A patent/CA2630193C/fr active Active
- 2006-11-17 CN CN200680043135XA patent/CN101312711B/zh active Active
- 2006-11-17 AT AT06818627T patent/ATE425742T1/de active
-
2009
- 2009-05-28 CY CY20091100567T patent/CY1109112T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CA2630193A1 (fr) | 2007-05-24 |
| PL1948131T3 (pl) | 2009-08-31 |
| CY1109112T1 (el) | 2014-07-02 |
| WO2007057201A2 (fr) | 2007-05-24 |
| EP1948131B1 (fr) | 2009-03-18 |
| DE502006003215D1 (de) | 2009-04-30 |
| CA2630193C (fr) | 2015-05-19 |
| PT1948131E (pt) | 2009-06-12 |
| SI1948131T1 (sl) | 2009-08-31 |
| PL1948131T6 (pl) | 2013-09-30 |
| EP1948131B3 (fr) | 2013-03-27 |
| US20090111770A1 (en) | 2009-04-30 |
| CN101312711B (zh) | 2013-07-17 |
| ES2324118T3 (es) | 2009-07-30 |
| JP2009515921A (ja) | 2009-04-16 |
| ES2324118T7 (es) | 2013-07-30 |
| WO2007057201A3 (fr) | 2007-08-02 |
| CN101312711A (zh) | 2008-11-26 |
| DE102005055275A1 (de) | 2007-05-24 |
| ATE425742T1 (de) | 2009-04-15 |
| US8648057B2 (en) | 2014-02-11 |
| EP1948131A2 (fr) | 2008-07-30 |
| HK1125027A1 (zh) | 2009-07-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1109112T1 (el) | Ελευθερη απο ιοντα δεξπανθενολης, ασβεστιου και φωσφορικο φαρμακευτικη συνθεση καθως και χρησιμοποιηση παραγοντων σχηματισμου χηλικων ενωσεων ασβεστιου και οφθαλμολογικα υποφερτου ρυθμιστη ιξωδους | |
| FR21C1064I2 (fr) | Compositions et procedes de traitement de troubles impliquant une proliferation cellulaire | |
| MX2021003819A (es) | Moduladores de alfa-1 antitripsina. | |
| PT1984357E (pt) | Compostos de 2,4-pirimidinadiamina para tratamento ou prevenção de doenças autoimunes | |
| DK1706122T3 (da) | Antivirale farmaceutiske sammensætninger | |
| GT200600009A (es) | Amino-imidazolonas para la inhibicion de beta-secretasa | |
| MX383346B (es) | Composiciones y metodos que comprenden variantes de serina proteasa. | |
| NO20075647L (no) | Kjemiske forbindelser | |
| CL2007002705A1 (es) | Composicion farmaceutica oftalmica autopreservada que comprende 0,04 a 0,9 mm de iones zinc donde la concentracion de aniones tamponantes es menor que 15 mm. | |
| IL190632A0 (en) | Biphenyl derivatives and pharmaceutical compositions containing the same | |
| BRPI0518334A2 (pt) | composiÇço de revestimento, mÉtodo de revestimento, revestimento, e, mÉtodo para preparar uma composiÇço de revestimento | |
| CR10766A (es) | Inhibidores de metaloproteasa derivados de heterociclicos | |
| EA200970377A1 (ru) | Композиции фенилалкиламинокарбамата | |
| MY199542A (en) | Cast-molding process for producing uv-absorbing contact lenses | |
| MX2018014524A (es) | Desinfectante para manos. | |
| WO2008057293A3 (fr) | Méthodes et compositions de décontamination des prions | |
| MX2019011506A (es) | Inhibicion de cinasa 1 de punto de control (chk1) para el tratamiento de cancer. | |
| MY137563A (en) | Ophthalmic composition | |
| MX2007001953A (es) | Enantiomeros de pirimidonas fusionadas seleccionadas y usos en el tratamiento y prevencion del cancer. | |
| CR20250103A (es) | Moduladores de la alfa-1 antitripsina | |
| PL1831209T3 (pl) | Inhibitory fosfataz cdc25 | |
| TW200730468A (en) | Methods for providing oxidatively stable ophthalmic compositions | |
| BRPI0409566A (pt) | compostos de ácido fosfÈnico como inibidores de serina protease | |
| LT2003075A (en) | Inhibitor of monoamine uptake | |
| PL1855838T3 (pl) | Proces dla wytwarzania soczewek okularowych |